Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Cirrhosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05201404
What this trial is testing

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Can-Fite BioPharma 471
Post-approval studies (Phase 4)Study completedNCT02344719
What this trial is testing

Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis

Who this might be right for
CirrhosisPortal Hypertension
Medical University of Vienna 30
Not applicableWithdrawnNCT04070508
What this trial is testing

Early Detection of Alcoholic Liver Disease

Who this might be right for
Alcoholic Liver DiseaseAlcoholic Fibrosis of LiverAlcoholic Cirrhosis+5 more
University of Pittsburgh
Testing effectiveness (Phase 2)Looking for participantsNCT07070700
What this trial is testing

Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Fudan University 56
Not applicableUnknownNCT04975477
What this trial is testing

CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102)

Who this might be right for
Compensated Advanced Chronic Liver Disease
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07042919
What this trial is testing

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaCirrhosisStage III Hepatocellular Carcinoma AJCC v8+1 more
Devalingam Mahalingam 59
Testing effectiveness (Phase 2)UnknownNCT05542615
What this trial is testing

Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).

Who this might be right for
Liver CirrhosisHepatitis C, ChronicEpigenetic Disorder
University of Guadalajara 60
Testing effectiveness (Phase 2)Ended earlyNCT04051853
What this trial is testing

Sorafenib PK in Patients With Advanced HCC and Child-Pugh B

Who this might be right for
BCLC Stage C HCCCP-B Liver Cirrhosis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 5
Testing effectiveness (Phase 2)Looking for participantsNCT06852287
What this trial is testing

Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Gall Bladder Cancer
Tianjin Medical University Cancer Institute and Hospital 33
Early research (Phase 1)Study completedNCT06973005
What this trial is testing

Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants

Who this might be right for
Advanced Chronic Liver DiseaseHealthy Participants
AstraZeneca 16
Not applicableNot Yet RecruitingNCT06537466
What this trial is testing

Ketogenic Diet in MASLD-related cACLD

Who this might be right for
Steatohepatitis, NonalcoholicSteatosis of LiverCirrhosis, Liver
University of Palermo 50
Not applicableLooking for participantsNCT07122622
What this trial is testing

2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices

Who this might be right for
Portal Hypertension Related to CirrhosisEsophageal Varices
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 450
Not applicableWithdrawnNCT02739581
What this trial is testing

Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis

Who this might be right for
Advanced Cirrhosis
Institute of Liver and Biliary Sciences, India
Post-approval studies (Phase 4)Study completedNCT00347009
What this trial is testing

Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis

Who this might be right for
Hepatitis B, ChronicCirrhosisFibrosis+1 more
GlaxoSmithKline 155
Testing effectiveness (Phase 2)Ended earlyNCT04497038
What this trial is testing

Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy

Who this might be right for
Advanced Adult Hepatocellular Carcinoma
University of Michigan Rogel Cancer Center 3
Post-approval studies (Phase 4)Ended earlyNCT02034279
What this trial is testing

The INFECIR-2 Albumin Prevention Study

Who this might be right for
Advanced Chronic Liver DiseaseUrinary InfectionPneumonia+2 more
EASL - CLIF Consortium 136
Testing effectiveness (Phase 2)UnknownNCT05402371
What this trial is testing

Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Fibrosis, LiverNAFLD
Hepion Pharmaceuticals, Inc. 120
Not applicableActive Not RecruitingNCT06136221
What this trial is testing

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease

Who this might be right for
Cirrhosis, LiverEnd Stage Liver DIseaseSymptoms and Signs+2 more
University of Pennsylvania 110
Post-approval studies (Phase 4)Study completedNCT00968695
What this trial is testing

Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.

Who this might be right for
CirrhosisAscites
Instituto Grifols, S.A. 33
Large-scale testing (Phase 3)Looking for participantsNCT06632444
What this trial is testing

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim 1,800
Next Page